[ Price : $8.95]
Evofem Biosciences discontinues its EVO100 development program of a drug to prevent chlamydia and gonorrhea in women.[ Price : $8.95]
FDA releases the form FDA-483 with 17 observations from an inspection at the Houston, TX-based Empower Pharmacy outsourcing facili...[ Price : $8.95]
Harm Reduction Therapeutics submits the first module of a planned rolling NDA for RiVive (3 mg intranasal naloxone), indicated as ...[ Price : $8.95]
Federal Register notice: FDA announces the user fee rates for fiscal year 2023 for medical devices.[ Price : $8.95]
Three Hyman, Phelps & McNamara attorneys say several recent drug approvals appear to signal a new FDA interest in using confirmato...[ Price : $8.95]
Merck exercises an option to collaborate with Moderna on a personalized cancer vaccine currently being evaluated in a Phase 2 tria...[ Price : $8.95]
Jiangsu Well Biotech (Jiang Su Sheng, China) recalls its Covid-19 Ag Rapid Test Devices because they were distributed without auth...[ Price : $8.95]
FDA says CDRH is launching the Total Product Life Cycle Advisory Program (TAP) pilot program called for in the MDUFA 5 reauthoriza...